Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/07/494   
Active ingredient: Lenalidomide
Indication: Treatment of chronic lymphocytic leukaemia
Sponsor: Celgene Europe Limited
1 Longwalk Road, Stockley Park, Uxbridge, Middlesex UB11 1DB, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/11/2007 Orphan designation EMEA/OD/068/07 (2007)5660 of 19/11/2007
26/10/2008 Change of name and/or address of sponsor
30/05/2011 Change of name and/or address of sponsor EMEA/OD/068/07